Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.49
-0.13 (-1.71%)
Dec 5, 2025, 4:00 PM EST - Market closed
Wave Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 196.22 | 302.08 | 200.35 | 88.5 | 150.56 | 184.5 | Upgrade
|
| Cash & Short-Term Investments | 196.22 | 302.08 | 200.35 | 88.5 | 150.56 | 184.5 | Upgrade
|
| Cash Growth | -36.90% | 50.77% | 126.39% | -41.22% | -18.39% | 25.37% | Upgrade
|
| Accounts Receivable | 10 | 1.42 | 21.09 | - | - | 30 | Upgrade
|
| Receivables | 10 | 1.42 | 21.09 | - | - | 30 | Upgrade
|
| Prepaid Expenses | 6.65 | 9.54 | 9.91 | 7.93 | 6.58 | 10.43 | Upgrade
|
| Other Current Assets | 2.62 | 7.35 | 4.02 | 2.11 | 5.42 | 5.11 | Upgrade
|
| Total Current Assets | 215.49 | 320.39 | 235.37 | 98.54 | 162.56 | 230.04 | Upgrade
|
| Property, Plant & Equipment | 22.07 | 28 | 35.72 | 44.13 | 40.64 | 45.43 | Upgrade
|
| Other Long-Term Assets | 3.82 | 3.82 | 3.86 | 3.72 | 3.8 | 3.77 | Upgrade
|
| Total Assets | 241.38 | 352.21 | 274.95 | 146.39 | 207.01 | 279.24 | Upgrade
|
| Accounts Payable | 14.49 | 16.26 | 12.84 | 16.92 | 7.28 | 13.8 | Upgrade
|
| Accrued Expenses | 16.49 | 21.08 | 16.83 | 17.55 | 14.86 | 11.97 | Upgrade
|
| Current Portion of Leases | 8.39 | 7.64 | 6.71 | 5.5 | 4.96 | 3.71 | Upgrade
|
| Current Unearned Revenue | 46.53 | 65.97 | 150.06 | 31.56 | 37.1 | 91.56 | Upgrade
|
| Total Current Liabilities | 85.9 | 110.95 | 186.44 | 71.52 | 64.2 | 121.04 | Upgrade
|
| Long-Term Leases | 11.38 | 17.77 | 25.4 | 32.12 | 24.96 | 25.59 | Upgrade
|
| Long-Term Unearned Revenue | 11.68 | 6.1 | 15.6 | 79.77 | 77.48 | 41.48 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.19 | - | 0.47 | Upgrade
|
| Total Liabilities | 108.96 | 134.82 | 227.45 | 183.6 | 166.64 | 188.59 | Upgrade
|
| Common Stock | 1,224 | 1,175 | 935.37 | 802.83 | 749.85 | 694.09 | Upgrade
|
| Additional Paid-In Capital | 174.08 | 156.45 | 129.24 | 119.44 | 87.98 | 71.57 | Upgrade
|
| Retained Earnings | -1,273 | -1,122 | -1,025 | -967.34 | -805.51 | -683.27 | Upgrade
|
| Comprehensive Income & Other | -0.19 | -0.26 | -0.12 | -0.03 | 0.18 | 0.39 | Upgrade
|
| Total Common Equity | 124.55 | 209.52 | 39.63 | -45.09 | 32.5 | 82.78 | Upgrade
|
| Shareholders' Equity | 132.42 | 217.39 | 47.5 | -37.22 | 40.37 | 90.65 | Upgrade
|
| Total Liabilities & Equity | 241.38 | 352.21 | 274.95 | 146.39 | 207.01 | 279.24 | Upgrade
|
| Total Debt | 19.77 | 25.4 | 32.12 | 37.61 | 29.92 | 29.31 | Upgrade
|
| Net Cash (Debt) | 176.45 | 276.67 | 168.23 | 50.88 | 120.65 | 155.19 | Upgrade
|
| Net Cash Growth | -37.82% | 64.46% | 230.63% | -57.83% | -22.26% | 35.40% | Upgrade
|
| Net Cash Per Share | 1.08 | 2.00 | 1.59 | 0.65 | 2.33 | 3.96 | Upgrade
|
| Filing Date Shares Outstanding | 167.18 | 153.49 | 122.28 | 98.1 | 60.84 | 49 | Upgrade
|
| Total Common Shares Outstanding | 160.29 | 153.04 | 119.16 | 86.92 | 59.84 | 48.78 | Upgrade
|
| Working Capital | 129.59 | 209.44 | 48.93 | 27.02 | 98.36 | 109 | Upgrade
|
| Book Value Per Share | 0.78 | 1.37 | 0.33 | -0.52 | 0.54 | 1.70 | Upgrade
|
| Tangible Book Value | 124.55 | 209.52 | 39.63 | -45.09 | 32.5 | 82.78 | Upgrade
|
| Tangible Book Value Per Share | 0.78 | 1.37 | 0.33 | -0.52 | 0.54 | 1.70 | Upgrade
|
| Machinery | - | 26.19 | 26.07 | 25.51 | 25.66 | 25.42 | Upgrade
|
| Construction In Progress | - | 0.35 | 0.29 | 0.32 | 0.03 | 0.08 | Upgrade
|
| Leasehold Improvements | - | 28.89 | 28.53 | 28.41 | 27.99 | 27.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.